RxDoctor Payments Data

Cristine Waldron

Adult Health · Braintree, MANPI 1639393374

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 245 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,955in general payments, 2019–2025

Across 245 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$698
  • Novo Nordisk$461
  • Lilly USA, LLC$400
  • Pfizer$281
  • Tolmar, Inc.$239
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,955100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,955 in reported general payments places this provider in the 95th percentile of 671 adult health providers in Massachusetts.

See all adult health providers in Massachusetts

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide15$15,611
EliquisApixaban18$15,506
Rosuvastatin Calcium96$3,377
Albuterol Sulfate HfaAlbuterol Sulfate38$1,105
Omeprazole48$1,047
Estradiol16$999
Metoprolol Succinate46$841
Atorvastatin Calcium67$820
Losartan Potassium73$768
Lisinopril66$705
Metformin Hcl ErMetformin Hcl22$479
Oxybutynin Chloride ErOxybutynin Chloride11$418
Clotrimazole24$400
Pantoprazole Sodium25$355
Famotidine33$336

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$400$15,61115 claims
PfizerEliquis$281$15,50618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 671 adult health providers in Massachusetts.

Other adult health in Braintree

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →